CBER Research Projects

Project Title

Growth Factors and Cell-Cell Interactions Governing Growth, Differentiation, and Transformation of B-Lineage Progenitor Population

Principal Investigator

Steven R. Bauer

Laboratory

Laboratory of Immunology and Developmental Biology; Division of Cellular and Gene Therapies; Office of Therapeutics Research and Review

Project Summary

We study differentiation of lymphoid cells as a model system for analyzing stem cell propagation and differentiation. This model allows us to examine the roles of cell-cell contact and exogenous growth factor signaling between a hematopoietic stem or progenitor B cell population and a stromal cell population of mesenchymal origin. We also study the process of cellular transformation in vitro and in vivo. These studies will help CBER regulate products such as hematopoietic, mesenchymal, neuronal, and more pluripotent stem cells. We have discovered and are elucidating the role of the dlk molecule in cell-cell interactions between stromal cells and progenitor B (proB) cells. Dlk is a member of the EGF-like homeotic gene family which influences cell fate during development. Our work has shown that modulation of the level of dlk expression on stromal cell surfaces can change the growth requirements and differentiation of proB cells in contact with them. Removal of IL-7 from proB cells interacting with normal storma with normal dlk levels leads to rapid differentiation followed by apoptotic cell death. In contrast, interaction with stromal cells with decreased dlk expression allows continued proB cell growth and does not lead to cell differentiation in the absence of IL-7. We are currently studying how cell-cell contact changes the growth factor requirements of proB cells, how the dlk molecule on the surface of the stromal cell changes gene expression in the proB cells, and how this interaction changes the apoptotic signal pathway that is normally induced in proB cells after removal of the growth factor IL-7. RT-PCR assays show increases in Notch-3 gene expression in proB cells grown without IL-7 but on stroma with low levels of dlk. This result suggests that dlk affects Notch signal transduction pathways in progenitor cells in the hematopoietic lineage. In addition, we recently used gene knock-out technology to derive a mouse strain lacking dlk using. The dlk knock-out strain is of small stature from birth. Since the dlk gene is imprinted and fetal expression is parentally controlled, even heterozygous animals carrying the parental knockout allele are affected. This animal model will provide much insight into cell-cell interactions in fetal development.

The influence of growth factors on stem cell populations is also studied in this model system. We are currently studying the effects of TGF-beta in our progenitor cell culture system. TGF-beta is a member of a gene family that profoundly affects differentiation and includes the activins, inhibin, and bone morphogenic proteins (BMPs). We observed that normal proB cells express TGF-beta receptors and are inhibited by exogenous TGF-beta. TGF-beta causes accumulation of proB cells in G1 stage of the cell cycle, stops proliferation, but does not induce apoptosis or differentiation. IL-7 can overcome these effects even in the continued presence of TGF-beta. We will continue to study this as a useful model relevant to the complex patterns of growth and differentiation control exercised by exogenous growth factors in stem cell cultures.

Our model system is also being used to study the role of oncogene dysregulation and anti-oncogenes in malignant transformation of a progenitor cell population. We have demonstrated that proB cells can be infected and transformed in vitro by viruses carrying c-myc with either v-abl or v-raf. We have also examined the role of oncogene mediated subversion of IL-7 signal transduction and found that, in contrast to abl-myc virus, the raf-myc virus can transform pre-B cells without constitutive activation of IL-7 JAK-STAT signaling. ProB cells transformed by either virus lose sensitivity to TGF-beta despite continued expression of receptors. These results show that the roles of both positive (IL-7) and negative (TGF-beta) growth factors include control of cell proliferation and loss of responsiveness can contribute to transformation.

Publications

• Nat Genet 1999 Aug;22(4):326
  FDA comments on phase I clinical trials without vector biodistribution data.
  Epstein S, Bauer S, Miller A, Pilaro A, Noguchi P
  Pub Med

• Oncogene 1998 Oct 22;17(16):2125-35
  Interaction of abl and raf with IL-7 signaling pathway and transformation of pre-B cells from resistant mice.
  Hilbert DM, Theisen PW, Rudikoff EK, Bauer SR
  Pub Med

• Mol Cell Biol 1998 Sep;18(9):5247-55
  Modulated expression of the epidermal growth factor-like homeotic protein dlk influences stromal-cell-pre-B-cell interactions, stromal cell adipogenesis, and pre-B-cell interleukin-7 requirements.
  Bauer SR, Ruiz-Hidalgo MJ, Rudikoff EK, Goldstein J, Laborda J
  Pub Med

• Blood 2001 May 1;97(9):2680-7
  Localization of recombination activating gene 1/green fluorescent protein (RAG1/GFP) expression in secondary lymphoid organs after immunization with T-dependent antigens in rag1/gfp knockin mice.
  Igarashi H, Kuwata N, Kiyota K, Sumita K, Suda T, Ono S, Bauer SR, Sakaguchi N
  Pub Med

• Mol Therapy 2000 Dec;2(6):532-4
  Working toward an adenoviral vector testing standard.
  Hutchins B, Sajjadi N, Seaver S, Shepherd A, Bauer SR, Simek S, Carson K, Aguilar-Cordova E
  Pub Med

Last Updated: 4/1/2002

Back to Top     Back to Index

Date created: September 25, 2003

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

FDA/Center for Drug Evaluation and Research